Butyrate, GLP-1, And Ozempic - Deepstash

Butyrate, GLP-1, And Ozempic

The researchers found that one metabolite, butyrate, was the driver of this effect. Butyrate, a short-chain fatty acid (SCFA) produced by certain gut bacteria in the fiber fermentation process, stimulates the release of GLP-1, which we've come to understand plays such an important role in communicating to the brain that feeling of 'fullness' when we eat. Semaglutide drugs like Ozempic synthetically create this gut-brain scenario, though in a more potent way that doesn't face the same kind of rapid deterioration as when it occurs naturally.

36

254 reads

CURATED FROM

IDEAS CURATED BY

xarikleia

“An idea is something that won’t work unless you do.” - Thomas A. Edison

If the title made you think “Well, science has spoken, the case is closed, let’s all jump on the Oatzempic train already!”, please do not read this.

Read & Learn

20x Faster

without
deepstash

with
deepstash

with

deepstash

Personalized microlearning

100+ Learning Journeys

Access to 200,000+ ideas

Access to the mobile app

Unlimited idea saving

Unlimited history

Unlimited listening to ideas

Downloading & offline access

Supercharge your mind with one idea per day

Enter your email and spend 1 minute every day to learn something new.

Email

I agree to receive email updates